Christopher M. Starr serves as Executive at Raptor Pharmaceutical Corp, where they oversee executive responsibilities. Since joining the company, Christopher M. Starr has executed 107 insider transactions totaling $7.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 2, 2012 involved selling 600 shares valued at $4.0K.
Christopher M. Starr currently holds 21,973 shares of Raptor Pharmaceutical Corp (RPTPD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher M. Starr has been a net seller of RPTPD stock. They have purchased $0 and sold $7.4M worth of shares.
Christopher M. Starr's most recent insider trade was on Apr 2, 2012, when they sold 600 shares at $6.68 per share.
Get notified when new Form 4 filings are submitted
| $6.66 |
| Discretionary |
| Apr 2, 2012 | RPTP | $28.5K | Option Exercise | 10,085 | $2.83 | Discretionary |
| Apr 2, 2012 | RPTP | $682 | Sale | 100 | $6.82 | Discretionary |
| Apr 2, 2012 | RPTP | $28.5K | Option Exercise | 10,085 | $2.83 | Discretionary |
| Apr 2, 2012 | RPTP | $67.8K | Sale | 10,085 | $6.72 | Discretionary |
| Sep 29, 2009 | RPTPD | $0 | Award | 699,370 | $N/A | Discretionary |